Sign in

CIK 0001817229

  • Emerging growth company

Vor Biopharma Inc.

Sign in to watch
Ticker
VOR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
811591163
Phone
+1 617-655-6580
Business address
500 BOYLSTON STREET, SUITE 1350, BOSTON, MA, 02116
  1. 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 999 shares (to pay taxes)
  2. 4 Shares withheld for taxes PRESIDENT AND CEO gave up 2,361 shares (to pay taxes)
  3. 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 876 shares (to pay taxes)
  4. 4 Shares withheld for taxes PRESIDENT AND CEO gave up 2,751 shares (to pay taxes)
  5. 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 1,146 shares (to pay taxes)
  6. 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 985 shares (to pay taxes)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Planned sale CHIEF MEDICAL OFFICER sold 14,645 shares at $1.39 ($20,357)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Shares withheld for taxes CHIEF MEDICAL OFFICER gave up 999 shares (to pay taxes)
  17. 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 834 shares (to pay taxes)
  18. 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 875 shares (to pay taxes)
  19. 4 Shares withheld for taxes PRESIDENT AND CEO gave up 2,361 shares (to pay taxes)
  20. 4 Shares withheld for taxes PRESIDENT AND CEO gave up 2,751 shares (to pay taxes)

Page 6 of 11 · 212 filings